Literature DB >> 21458829

Psychogenic parkinsonism.

Mark Hallett1.   

Abstract

Parkinsonism can be psychogenic, and psychogenic parkinsonism is about 10% of psychogenic movement disorder patients. Patients can present with any feature or combination of features of organic Parkinson's disease. There are clinical clues that can lead to the correct diagnosis, and laboratory testing with clinical neurophysiology or DAT (dopamine transporter) scanning can be helpful as well. Patients may have both organic Parkinson's disease and psychogenic parkinsonism, and this might be considered a psychologically induced aggravation of the organic disorder. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21458829      PMCID: PMC3139799          DOI: 10.1016/j.jns.2011.03.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

Review 1.  Physiology of psychogenic movement disorders.

Authors:  Mark Hallett
Journal:  J Clin Neurosci       Date:  2010-05-20       Impact factor: 1.961

2.  Analysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease.

Authors:  R Agostino; A Berardelli; A Formica; F Stocchi; N Accornero; M Manfredi
Journal:  Mov Disord       Date:  1994-05       Impact factor: 10.338

3.  Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.

Authors:  R de la Fuente-Fernández; T J Ruth; V Sossi; M Schulzer; D B Calne; A J Stoessl
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

4.  Diagnostic and pathophysiological aspects of psychogenic tremors.

Authors:  G Deuschl; B Köster; C H Lücking; C Scheidt
Journal:  Mov Disord       Date:  1998-03       Impact factor: 10.338

5.  Time-frequency analysis of tremors.

Authors:  P E O'Suilleabhain; J Y Matsumoto
Journal:  Brain       Date:  1998-11       Impact factor: 13.501

6.  Accelerometry to distinguish psychogenic from essential or parkinsonian tremor.

Authors:  K E Zeuner; R O Shoge; S R Goldstein; J M Dambrosia; M Hallett
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

Review 7.  DAT imaging in drug-induced and psychogenic parkinsonism.

Authors:  Eduardo Tolosa; Miguel Coelho; Marisol Gallardo
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

8.  Identification of psychogenic, dystonic, and other organic tremors by a coherence entrainment test.

Authors:  John McAuley; John Rothwell
Journal:  Mov Disord       Date:  2004-03       Impact factor: 10.338

9.  Psychogenic movement disorders: frequency, clinical profile, and characteristics.

Authors:  S A Factor; G D Podskalny; E S Molho
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

10.  Psychogenic parkinsonism.

Authors:  A E Lang; W C Koller; S Fahn
Journal:  Arch Neurol       Date:  1995-08
View more
  7 in total

Review 1.  An update on psychogenic movement disorders.

Authors:  Aviva Ellenstein; Sarah M Kranick; Mark Hallett
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 2.  Functional (psychogenic) movement disorders - Clinical presentations.

Authors:  Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2015-09-03       Impact factor: 4.891

3.  Recognizing uncommon presentations of psychogenic (functional) movement disorders.

Authors:  José Fidel Baizabal-Carvallo; Robert Fekete
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-01-21

4.  Principles of Electrophysiological Assessments for Movement Disorders.

Authors:  Kai-Hsiang Stanley Chen; Robert Chen
Journal:  J Mov Disord       Date:  2020-01-31

5.  Dopamine transporter imaging in psychogenic parkinsonism and neurodegenerative parkinsonism with psychogenic overlay: a report of three cases.

Authors:  Chizoba C Umeh; Zsolt Szabo; Gregory M Pontone; Zoltan Mari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-09-10

6.  Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study.

Authors:  Manuel Menéndez-González; Francisco Tavares; Nahla Zeidan; José M Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Aging Neurosci       Date:  2014-04-01       Impact factor: 5.750

7.  A Positive 'Pointing Test' in a Parkinson's Disease Patient.

Authors:  Heidemarie Zach; Wieneke L J Gerrits; Bart P van de Warrenburg; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.